Insiders · Profile

Celano Michael

Chief Financial Officer at Larimar Therapeutics · Director at ORASURE TECHNOLOGIES. Filing since 13 Aug 2008. CIK 0001377582

Company
Date
Role
Action
Shares
Amount
Of holding
17 May 2023
Chief Financial Officer
Bought
5,000
$18.63K
4.6%
16 Sep 2022
Chief Financial Officer
Bought
31,746
$100.00K
opened
12 Aug 2022
Director
Bought
12,000
$53.92K
12.0%
5 May 2017
Director
Sold, plan not stated
44,962
$672.18K
54.1%
2 Mar 2017
Director
Sold, plan not stated
15,000
$180.00K
15.3%
9 Feb 2017
Director
Sold, plan not stated
10,000
$100.60K
10.7%
31 Jan 2017
Director
Sold, plan not stated
15,000
$131.70K
13.9%
13 Aug 2008
Director
Bought
10,000
$45.91K
opened
8 decisions on file.